R&D & Funding
If you anticipate any impact on clinical trials supplies over the coming weeks, then please get in touch with firstname.lastname@example.org, this mailbox will be monitored over the Christmas period.
There is no change to the current arrangements for EU-related R&D and funding during the transition period until 31 December 2020.
Global Talent Visa
The government has announced changes to the immigration rules for researchers and scientists. The Global Talent Visa is a new route for researchers to work and live in the UK.
After the end of the transition period
At the end of the Transition Period, depending on the terms of any future relationship agreed with the EU, there are likely to be changes that could affect to business’ R&D activities and funding. The links to guidance below include some previous no deal advice provided by the Government, which could be relevant if there is no agreement on a future relationship with the EU before the end of 2020.
UK regulations on access to genetic resources and the fair and equitable sharing of benefits arising from their utilisation (the Nagoya Protocol) that will continue to be operable after the UK leaves the EU